ResMed Inc. vs Royal Bank of Canada — how do they compare? ResMed Inc. trades at $197.45 (market cap $28.81B), while Royal Bank of Canada trades at $210.37 (market cap $289.51B). The key difference: Royal Bank of Canada is far larger — about 10× ResMed Inc.'s market cap, and Royal Bank of Canada pays the higher dividend (2.42%). Which is the better fit depends on your goals.
| RMD | RY | |
|---|---|---|
Market Cap | $28.81B | $289.51B |
Sector | Health | Financials |
52-Week High | $293.73 | $217.87 |
52-Week Low | $182.82 | $128.46 |
Enterprise Value | $27.99B | — |
Dividend Yield | 1.21% | 2.42% |
Trailing returns across standard periods
Latest headlines on both assets
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →